Page last updated: 2024-08-24

triazoles and Nervous System Disorders

triazoles has been researched along with Nervous System Disorders in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's6 (75.00)29.6817
2010's0 (0.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Geddam, JJB; K, SR; Mummadi, MK; P, S; Pandurangi, R; Rajendran, A; Ramachandrappa, NK; Sinha, SN; Sreenu, P1
Akdogan, E; Aksoy, F; Altunayoglu, V; Aydin, K; Koksal, I; Omay, SB; Sozen, EE; Yilmaz, M1
Cociglio, M; Eiden, C; Hansel-Esteller, S; Hillaire-Buys, D; Margueritte, G; Palenzuela, G; Peyriere, H1
Chatterjee, NA; Das, K; Dobrowsky, W; Huilgol, NG; Kagiya, VT; Tatsuzaki, H1
Barone, S; Moser, VC1
Baraldi, PG; Cipriani, S; Gianfriddo, M; Giovannini, MG; Melani, A; Pedata, F; Vannucchi, MG1
Puzantian, T; Shaw, RJ1
Canger, R; Henriksen, O; Karolchyk, MA; Pålhagen, S; Rivière, ME; van Parys, JA1

Trials

2 trial(s) available for triazoles and Nervous System Disorders

ArticleYear
Sanazole as a sensitizer of hypoxic cells with radical radiation in the treatment of advanced cancer of cervix an Indian experience.
    Indian journal of cancer, 2002, Volume: 39, Issue:2

    Topics: Adult; Aged; Female; Humans; India; Middle Aged; Nervous System Diseases; Radiation-Sensitizing Agents; Radiotherapy Dosage; Survival Rate; Triazoles; Uterine Cervical Neoplasms

2002
Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy.
    Epilepsy research, 2001, Volume: 43, Issue:2

    Topics: Adult; Anticonvulsants; Double-Blind Method; Drug Therapy, Combination; Epilepsy; Female; Half-Life; Humans; Incidence; Male; Middle Aged; Nervous System Diseases; Seizures; Triazoles

2001

Other Studies

6 other study(ies) available for triazoles and Nervous System Disorders

ArticleYear
Investigation of an acute neurological outbreak in Eluru, India, 2020.
    PloS one, 2021, Volume: 16, Issue:11

    Topics: Chromatography, Liquid; Disease Outbreaks; Female; Food Contamination; Heavy Metal Poisoning; Humans; India; Male; Mycotoxins; Nervous System Diseases; Organothiophosphates; Pesticides; Tandem Mass Spectrometry; Triazoles

2021
Voriconazole-induced neuropathy.
    Chemotherapy, 2008, Volume: 54, Issue:3

    Topics: Adolescent; Adult; Female; Humans; Leukemia; Male; Nervous System Diseases; Pyrimidines; Triazoles; Voriconazole

2008
Posaconazole-increased vincristine neurotoxicity in a child: a case report.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:4

    Topics: Antifungal Agents; Antineoplastic Agents, Phytogenic; Child; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Mycoses; Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Triazoles; Vincristine

2009
The effects of perinatal tebuconazole exposure on adult neurological, immunological, and reproductive function in rats.
    Toxicological sciences : an official journal of the Society of Toxicology, 2004, Volume: 77, Issue:1

    Topics: Animals; Artifacts; Diagnostic Errors; Female; Fungicides, Industrial; Immune System; Nervous System Diseases; Neurons; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Reproduction; Triazoles

2004
The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia.
    Brain research, 2006, Feb-16, Volume: 1073-1074

    Topics: Analysis of Variance; Animals; Blotting, Western; Brain; Brain Injuries; Brain Ischemia; Disease Models, Animal; Enzyme Activation; Functional Laterality; Immunohistochemistry; Male; Microscopy, Confocal; Motor Activity; Nervous System Diseases; Neurologic Examination; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Wistar; Triazoles

2006
Nefazodone and symptoms suggesting neurotoxicity: a case report.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:12

    Topics: Adult; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Nervous System Diseases; Piperazines; Psychotic Disorders; Triazoles

1996